Celecoxib, 169590-42-5 API Manufacturers&Suppliers in India

To create a 5000-word article on Celecoxib (CAS: 169590-42-5) API Manufacturers and Suppliers in India, we can structure the content in a detailed, comprehensive manner. The article will explore various aspects, including the chemical properties, therapeutic uses, manufacturing process, regulatory standards, and market trends for Celecoxib API. Below is a detailed outline, along with the first section of the article.

Outline for the Article:





    • Importance of Active Pharmaceutical Ingredients (APIs)

    • Introduction to Celecoxib (CAS: 169590-42-5) as a significant API in pain management

    • Role of India as a global hub for API manufacturing

    • Overview of Celecoxib API Manufacturers and Suppliers in India



  1. What is Celecoxib?

    • Chemical structure and composition

    • Mechanism of action and therapeutic benefits

    • Differences between Celecoxib and other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)



  2. Therapeutic Applications of Celecoxib

    • The role of Celecoxib in the treatment of osteoarthritis, rheumatoid arthritis, and other inflammatory conditions

    • Celecoxib's role in post-operative pain management and cancer-related pain

    • Overview of Celecoxib in the context of its FDA approval and international use



  3. The Manufacturing Process of Celecoxib API

    • Step-by-step breakdown of the synthesis of Celecoxib

    • Use of semi-synthetic methods in its production

    • Challenges and complexities involved in Celecoxib API manufacturing

    • Importance of quality control and CGMP (Current Good Manufacturing Practices) adherence



  4. Celecoxib API Manufacturers in India

    • Overview of the Indian pharmaceutical industry’s role in Celecoxib API production

    • Key manufacturers such as KekulePharma, Sun Pharma, Aurobindo Pharma, and others

    • Manufacturing capabilities, infrastructure, and scale of operations

    • India’s competitive edge in API production: cost-effectiveness, advanced technology, and skilled workforce



  5. Celecoxib API Suppliers in India

    • Overview of the distribution network for Celecoxib API

    • Key suppliers and their international presence

    • Importance of reliable supply chains and logistics in the pharmaceutical sector

    • Regulatory and compliance standards followed by suppliers in India



  6. Regulatory Compliance and Quality Assurance

    • Regulatory standards for Celecoxib API (FDA, EMA, WHO, CDSCO)

    • CGMP compliance and its importance in maintaining product quality and safety

    • Testing and certification processes for Celecoxib API

    • Quality control measures during the production and packaging phases



  7. Market Trends and Global Demand for Celecoxib

    • Growing market demand for Celecoxib globally, driven by increasing incidence of arthritis and other inflammatory disorders

    • Market analysis for Celecoxib, including pricing trends and market forecasts

    • Opportunities and challenges for Celecoxib API manufacturers in India



  8. Challenges in the Production and Supply of Celecoxib API

    • Supply chain challenges and logistical issues

    • Raw material availability and pricing pressures

    • Regulatory hurdles and compliance with international standards

    • Competition from other global manufacturers



  9.  

    • Recap of India’s leadership role in Celecoxib API production and supply

    • The future of Celecoxib API in the global pharmaceutical market

    • India’s commitment to excellence in product quality and maintaining a competitive edge in API manufacturing








Sample Sections for the Article:


1. Introduction


Active Pharmaceutical Ingredients (APIs) are the core components of pharmaceutical products that provide the therapeutic effect necessary for treating a wide variety of medical conditions. In today’s global pharmaceutical market, Celecoxib (CAS: 169590-42-5) is one of the most widely used non-steroidal anti-inflammatory drugs (NSAIDs), known for its effectiveness in treating pain and inflammation. Celecoxib is especially crucial for managing chronic conditions like osteoarthritis and rheumatoid arthritis, as well as for post-operative pain management.

India, as one of the world’s largest producers of pharmaceuticals, plays a critical role in the manufacturing and supply of Celecoxib API. With its advanced manufacturing capabilities, cost-effective solutions, and skilled workforce, India has become a key player in supplying high-quality Celecoxib API to pharmaceutical companies across the globe.

This article explores the role of India's Celecoxib API manufacturers and suppliers, providing a comprehensive overview of the chemical properties, manufacturing processes, market trends, and the global demand for Celecoxib API. Through this, we will gain insights into how India has positioned itself as a leading supplier in the global API market.




2. What is Celecoxib?


Celecoxib is a selective COX-2 inhibitor, which means it selectively blocks the cyclooxygenase-2 (COX-2) enzyme responsible for producing inflammatory prostaglandins. Unlike traditional nonsteroidal anti-inflammatory drugs (NSAIDs), which inhibit both COX-1 and COX-2, Celecoxib’s selectivity allows it to reduce pain and inflammation with a reduced risk of gastrointestinal side effects like ulcers and bleeding.
Chemical Structure and Composition

Celecoxib is a sulfonamide compound with a pyrazole ring structure. Its molecular formula is C17H14F3N3O2S, and it contains a trifluoromethyl group (CF3), which plays a key role in its COX-2 selectivity. The drug is typically administered as oral tablets and is available in various dosages, including 100 mg and 200 mg formulations.
Mechanism of Action

As a COX-2 inhibitor, Celecoxib works by binding to the active site of the COX-2 enzyme, thus inhibiting the enzyme’s activity and reducing the synthesis of prostaglandins that cause pain, inflammation, and fever. By selectively targeting COX-2, Celecoxib provides effective anti-inflammatory and analgesic effects without the unwanted gastric side effects associated with non-selective NSAIDs.
Therapeutic Benefits

Celecoxib is primarily used for managing:

  • Osteoarthritis: A degenerative joint disease that causes pain, stiffness, and inflammation.

  • Rheumatoid Arthritis: An autoimmune disorder characterized by chronic inflammation of the joints.

  • Acute Pain: Especially post-operative pain or pain resulting from minor surgeries.

  • Ankylosing Spondylitis: A form of arthritis that affects the spine and large joints.


It is often prescribed when patients cannot tolerate traditional NSAIDs due to gastrointestinal concerns. Celecoxib’s selective inhibition of COX-2 makes it an effective option for pain relief with a favorable safety profile.




3. Therapeutic Applications of Celecoxib


Celecoxib's role in the treatment of arthritis, pain management, and inflammatory conditions makes it one of the most important drugs in the NSAID category. Its widespread use is primarily due to its effective pain-relieving properties and relatively safer profile compared to traditional NSAIDs.
Osteoarthritis and Rheumatoid Arthritis

In both osteoarthritis and rheumatoid arthritis, Celecoxib is used to reduce inflammation, alleviate pain, and improve mobility in the joints. For patients suffering from these chronic conditions, Celecoxib provides a long-term treatment option with fewer gastrointestinal side effects than other NSAIDs.
Post-Operative Pain Management

Celecoxib is also widely used in managing acute pain following surgery. Its ability to reduce inflammation and alleviate pain makes it an essential drug for post-operative recovery, offering patients significant relief and improving recovery time.
Cancer Pain and Other Applications

Emerging evidence suggests that Celecoxib may have potential benefits in the management of cancer-related pain. The drug's anti-inflammatory effects may help reduce pain and inflammation associated with certain types of cancer, although its use in oncology is still under clinical investigation.




4. The Manufacturing Process of Celecoxib API


The manufacturing process of Celecoxib API is intricate and requires precise control over chemical reactions and formulation steps to ensure the purity and potency of the final product. The process typically involves semi-synthetic methods that combine synthetic organic chemistry with the preparation of intermediate compounds.
Synthesis of Celecoxib

The synthesis of Celecoxib begins with the formation of a pyrazole ring structure, which is then functionalized with a trifluoromethyl group to achieve the desired COX-2 selectivity. The process involves several steps, including coupling reactions, reduction, and sulfonation, followed by the incorporation of a sulfonamide group.
Quality Control and Challenges

Given the potency of Celecoxib and the need for precision, maintaining strict quality control is essential throughout the manufacturing process. Adherence to CGMP (Current Good Manufacturing Practices) ensures that the API is produced with the highest standards of safety and efficacy. Quality control measures include:

  • Ensuring purity and potency through rigorous testing.

  • Preventing contamination through controlled manufacturing environments.

  • Utilizing advanced equipment for the synthesis, purification, and packaging of Celecoxib API.


Challenges in Manufacturing

One of the main challenges in manufacturing Celecoxib is ensuring high yields while maintaining purity. The complex chemical structure of Celecoxib requires careful optimization of each reaction step to minimize side products and maximize the active compound's output.




5. Celecoxib API Manufacturers in India


India is one of the largest producers and exporters of pharmaceutical APIs globally, including Celecoxib. The country boasts a large number of API manufacturers that are CGMP-compliant and have extensive experience in producing high-quality, highly potent APIs.

Some of the leading Celecoxib API manufacturers in India include:

  • KekulePharma: Known for its advanced production capabilities and commitment to product quality, KekulePharma manufactures Celecoxib API to meet international standards.

  • Sun Pharmaceutical Industries: A global leader in the pharmaceutical industry, Sun Pharma is a major manufacturer of Celecoxib API, supplying it to markets around the world.

  • Aurobindo Pharma: With a strong focus on high-quality API production, Aurobindo Pharma manufactures Celecoxib API in large quantities to meet the needs of its global customers.


 

Leave a Reply

Your email address will not be published. Required fields are marked *